Justia Medical Malpractice Opinion Summaries

A twenty-one-month-old child suffered seizures and respiratory distress after a fall at home. His mother called 911, and basic life support EMTs arrived, followed by advanced life support paramedics. The paramedics, employed by Atlantic Ambulance Corporation, administered medications and attempted multiple intubations to open his airway. They communicated twice by phone with Dr. Niti Sharma, a licensed emergency physician, who gave them orders to administer drugs and to intubate the child. After several unsuccessful intubation attempts and continued resuscitation efforts, the child was transported into the hospital, where he was reintubated and resuscitated. He was discharged with an anoxic brain injury and other significant health repercussions.Plaintiffs, the child’s parents, sued Atlantic Ambulance Corporation, its paramedics, and other related parties, alleging negligence and reckless conduct caused the injuries. Defendants moved for summary judgment, arguing immunity under New Jersey’s Emergency Medical Services Act (EMSA), which shields paramedics from civil liability when they perform advanced life support services “in good faith” and “in accordance with” the EMSA. The Superior Court, Law Division, granted summary judgment, finding the paramedics followed physician orders and maintained appropriate communication. The Appellate Division affirmed, concluding the paramedics’ actions met statutory requirements for immunity, and rejected plaintiffs’ argument that frequent or continuous communication with the physician was required.The Supreme Court of New Jersey reviewed whether the paramedics acted “in accordance with the act” for purposes of statutory immunity. The Court held that the paramedics maintained direct voice communication and took orders from a licensed physician as required by the EMSA, and that the statute does not mandate continuous communication or specific recontact criteria. The Court affirmed summary judgment for the defendants, granting them immunity under N.J.S.A. 26:2K-14. View "Almonte v. Township of Union" on Justia Law

Crystal Walcott Spill's estate and beneficiaries filed a wrongful death suit against several doctors, including Dr. Steven Paganessi and his medical group, alleging negligence during a surgical procedure that led to Spill's death. Spill, who had lupus, was under the care of Dr. Jenny Diep, a New York-based rheumatologist, and Dr. Jacob Markovitz, a New Jersey-based gynecologist. Before the surgery, Dr. Diep increased Spill's blood pressure medication dosage and recommended she see a nephrologist. Spill saw Dr. Holly Koncicki, a New York-based nephrologist, who conducted lab tests but did not receive the results before the surgery. Spill suffered a cardiac event during the procedure and died the same day. The lab results, available after her death, showed critically elevated creatinine and potassium levels.The trial court dismissed Dr. Diep from the case due to lack of personal jurisdiction and denied the defendants' motion to include her on the verdict form for fault allocation. The Appellate Division affirmed, holding that an out-of-state individual over whom New Jersey courts lack personal jurisdiction cannot be included for fault allocation.The Supreme Court of New Jersey reviewed the case and affirmed the Appellate Division's decision, with modifications. The Court held that an individual outside New Jersey's jurisdiction is not a "party" under the Comparative Negligence Act (CNA) for fault allocation purposes. However, such an individual may be considered a joint tortfeasor under the Joint Tortfeasors Contribution Law (JTCL), allowing defendants to seek contribution in a relevant jurisdiction if a judgment is rendered against them. The Court did not agree with the Appellate Division's view that the model civil jury instruction on causation mitigates any unfairness to the defendants. View "Estate of Spill v. Markovitz" on Justia Law

Plaintiffs, administrators of the Estate of April Carden, filed a medical malpractice complaint against Hackensack Meridian Health, Dr. Alok Goyal, and South Plainfield Primary Care. They alleged that Carden's death was due to Allopurinol prescribed by Dr. Goyal, claiming negligence and vicarious liability. Dr. Goyal and SPPC's answer included a Specialty Statement indicating they practiced internal medicine and gastroenterology. Plaintiffs provided an affidavit of merit (AOM) from Dr. Fitzgibbons, a board-certified internist. Defendants argued Dr. Fitzgibbons was unqualified as she was not certified in gastroenterology.The trial judge denied defendants' motions to dismiss, finding the treatment involved internal medicine. Alternatively, the judge ruled that the AOM from Dr. Fitzgibbons was sufficient under Buck v. Henry. Defendants' motion for reconsideration was also denied. The Appellate Division reversed, requiring an AOM from a physician certified in each of Dr. Goyal's specialties, and remanded for further proceedings.The Supreme Court of New Jersey reviewed the case. It held that when a defending physician practices in multiple specialties, an AOM from a physician specializing in any one of those specialties suffices. The Court found that Dr. Goyal's treatment involved both internal medicine and gastroenterology, and thus, the AOM from Dr. Fitzgibbons, a board-certified internist, was adequate. The Court reversed the Appellate Division's judgment and remanded for further proceedings, emphasizing that plaintiffs must still prove negligence at trial. View "Wiggins v. Hackensack Meridian Health" on Justia Law

In this consolidated appeal, the court examined whether internal reports and documents created after alleged adverse events at nursing and assisted living facilities are discoverable or privileged under the New Jersey Patient Safety Act (PSA). In the first case, the plaintiff, Madeline Keyworth, claimed injuries from two falls at a skilled nursing facility and sought the facility’s internal incident reports. In the second case, the plaintiffs, Suzanne and Jonathan Bender, sought an incident report regarding an alleged attack on Diane Bender by another resident at an assisted living facility. Both facilities argued that the requested materials were privileged under the PSA’s self-critical-analysis privilege.The trial courts in both cases found that the self-critical-analysis privilege did not apply and ordered the defendants to disclose the materials. The Appellate Division reversed these decisions, concluding that the defendants had complied with the PSA’s procedural requirements, thus making the documents privileged and not subject to discovery.The Supreme Court of New Jersey reviewed the cases and held that the facilities did not comply with the PSA’s procedural requirements. Specifically, the court noted that the PSA requires a patient safety committee to operate independently from any other committee within the facility. The defendants’ certifications revealed that their committees did not adhere to this requirement, as they performed dual functions related to both patient safety and quality assurance. Consequently, the court determined that the disputed documents were not privileged under the PSA and were subject to discovery.The court reversed the Appellate Division’s judgment and remanded the cases to the trial courts for further proceedings consistent with its opinion. The main holding was that the facilities’ failure to comply with the PSA’s procedural requirements meant that the self-critical-analysis privilege did not apply to the disputed documents. View "Keyworth v. CareOne at Madison Avenue" on Justia Law

Plaintiff’s daughter, Alexandrianna Lowe, who had an opioid addiction, was admitted to Hackensack Meridian Jersey Shore University Medical Center (JSUMC) for complications related to Type 1 diabetes. Two days later, Lowe was found unresponsive, and hospital staff administered anti-opioid medication but failed to check her blood sugar levels. An autopsy revealed no illicit drugs in her system. Plaintiff filed a complaint against JSUMC and others, alleging negligence. At the time of filing, plaintiff had not been appointed administratrix ad prosequendum of her daughter’s estate and did not have access to Lowe’s medical records.The trial court dismissed Dr. Michael Carson from the case as he was not involved in the events leading to Lowe’s death. Plaintiff submitted an Affidavit of Merit (AOM) by Dr. Joseph Fallon, which defendants argued was insufficient because it did not name the surviving defendants, did not state that Dr. Fallon was a similarly licensed physician, and did not indicate that Dr. Fallon reviewed Lowe’s medical records. Without holding a Ferreira conference, the trial court dismissed the complaint with prejudice for failure to submit a sufficient AOM. The Appellate Division affirmed the dismissal.The Supreme Court of New Jersey reviewed the case and held that the AOM submitted by plaintiff complied with N.J.S.A. 2A:53A-27. The Court found that the AOM statute does not require the affiant to state that they reviewed medical records or to name a specific defendant by name. The Court emphasized the importance of holding a timely and effective Ferreira conference to resolve issues related to the AOM. The Court reversed the Appellate Division’s decision and remanded the case for further proceedings, including consideration of plaintiff’s motion to amend her complaint to add Dr. Vikas Singh as a defendant. View "Moschella v. Hackensack Meridian Jersey Shore University Medical Center" on Justia Law

In this products liability matter involving “pelvic mesh” medical devices, the New Jersey Supreme Court considered whether defendant C.R. Bard, Inc., was denied a fair trial by the trial court’s determination that defendant could not present 510(k) clearance evidence -- evidence that, pursuant to 21 U.S.C. § 360c, the devices were allowed to be marketed without premarket clinical trials -- to counter the product liability claims brought by plaintiffs Mary and Thomas Walsh McGinnis. North Carolina surgeon Dr. Elizabeth Barbee implanted Bard’s “Align TO” and “Avaulta Solo” pelvic mesh devices. In the months following surgery, McGinnis had to undergo numerous invasive surgeries to remove the mesh and repair internal damage, with limited success. In 2011, plaintiffs filed suit against defendant Bard under North Carolina law. Counsel agreed that the substantive issues would be tried under the law of North Carolina but that the issue of damages would be tried under New Jersey law. Plaintiffs moved in limine to bar defendant from presenting any evidence of the devices’ 510(k) clearance to the jury. The trial court found the 510(k) evidence inadmissible. The Appellate Division reversed, holding that the exclusion of any 510(k) evidence deprived defendant of a fair trial on the issue of negligence. The Supreme Court agreed that 510(k) evidence was generally inadmissible because the 510(k) clearance process solely determines substantial equivalency, and not safety and efficacy. However, in a products liability claim premised on the reasonableness of a manufacturer’s conduct in not performing clinical trials or studies, the Court held evidence of 510(k) clearance had significant probative value under N.J.R.E. 401 that was not substantially outweighed by the risk of prejudice and potential juror confusion under N.J.R.E. 403. Therefore, under the specific facts and circumstances of this case, the Supreme Court affirmed the Appellate Division and remanded for a new trial. The Court disagreed with the Appellate Division’s decision regarding the scope and admissibility of 510(k) evidence and a Rule 104 hearing. To this, the Supreme Court believed the scope and admissibility of 510(k) evidence should be resolved at the hearing on a motion in limine, which was how the issue was and, presumably, would be raised. View "Hrymoc v. Ethicon, Inc." on Justia Law

T.L. consulted Dr. Jack Goldberg for a blood condition. In October 2010, Dr. Goldberg told T.L. about a new medication, Pegasys. After taking Pegasys, T.L. experienced a number of symptoms, but Dr. Goldberg advised that T.L. should continue taking Pegasys. T.L. began experiencing severe pain in her neck and both arms, requiring hospitalization and rehabilitation. T.L. was diagnosed with inflammation of the spinal cord and experienced partial paralysis on her right side. T.L. brought suit against Dr. Goldberg and his employer, Penn Medicine Cherry Hill. T.L. claimed that Dr. Goldberg deviated from accepted standards of care by prescribing Pegasys to her because she was diagnosed with, and took medication for, chronic depression. During Dr. Goldberg’s deposition, when asked whether he was aware of any studies in the Journal of Clinical Oncology pertaining to the use of Pegasys to treat patients with T.L.’s condition, Dr. Goldberg answered “no.” On T.L.’s motion, the court barred Dr. Goldberg from using any medical literature at trial that was not produced during the course of discovery. At trial, Dr. Goldberg testified that he prescribed Pegasys to T.L. because he relied upon a clinical trial, published in the Journal of Clinical Oncology in 2009, that included patients with a history of depression. T.L.’s counsel did not object. The jury found that Dr. Goldberg did not deviate from the applicable standard of care. T.L. was granted a new trial on grounds that Dr. Goldberg’s discussion of the 2009 publication constituted reversible error. Dr. Goldberg appealed as of right based on a dissenting justice in the Appellate Division's reversal of the trial court. The New Jersey Supreme Court reversed, finding there was no demonstration that the changed testimony caused prejudice to T.L., and the plain error standard did not compel reversal, "especially because counsel’s failure to object was likely strategic." Under the circumstances, T.L. was not entitled to a new trial. View "T.L. v. Goldberg" on Justia Law

This appeal arose out of a discovery dispute in a medical malpractice action involving a hospital’s and its staff’s care of a patient. The parties disagreed over the boundaries of privileged material under the Patient Safety Act (PSA), N.J.S.A. 26:2H-12.23 to -12.25c, and plaintiff’s ability to receive responsive discovery in order to prepare her action. The New Jersey Supreme Court affirmed the appellate panel’s order shielding the redacted document at issue from discovery because the PSA’s self-critical-analysis privilege prevents its disclosure. The Court also affirmed the determination that, when reviewing a discovery dispute such as this, a trial court should not be determining whether a reportable event under the PSA has occurred. The Court reversed the judgment to the extent it ended defendants’ discovery obligation with respect to this dispute, finding that defendants had an unmet discovery duty under Rule 4:17-4(d) that had to be addressed. The matter was remanded for further proceedings. View "Brugaletta v. Garcia" on Justia Law

This appeal stemmed from plaintiff Lucia Serico’s motion for attorney’s fees and other litigation expenses pursuant to Rule 4:58 after a jury trial on medical malpractice claims against Robert Rothberg, M.D. At issue was whether Serico could collect attorney’s fees from Rothberg despite entering into a “high-low agreement” that limited the amount she could recover at trial to $1,000,000. Based on the expressed intent of the parties and the context of the agreement, the New Jersey Supreme Court found the agreement set $1,000,000 as the maximum recovery. Therefore, Serico could not seek additional litigation expenses allowed by Rule 4:58. View "Serico v. Rothberg" on Justia Law

T.T., individually and on behalf of her three-year-old daughter, A.T., filed this medical malpractice action seeking damages from a hospital and several medical professionals for injuries caused during the child’s birth.1 The trial court granted summary judgment to defendants and dismissed the action with prejudice because plaintiff failed to serve a timely affidavit of merit. The Appellate Division affirmed, rejecting plaintiff’s argument that the circumstances should have supported entry of a dismissal without prejudice under Rule 4:37-1(b). After review, the New Jersey Supreme Court reversed the grant of summary judgment to defendants and remanded for further proceedings. The Court determined that a combination of circumstances (not the least of which was the failure to schedule a pretrial conference to address the affidavit of merit requirement as New Jersey case law directed), warranted allowing the untimely affidavit to be filed. "The equities militate in favor of permitting a facially meritorious action to proceed here, particularly because any prejudice to defendants may be addressed through costs imposed by the trial court. We decline to approve recourse to a voluntary dismissal without prejudice under Rule 4:37-1(b) as an appropriate avenue for addressing failures to comply with the affidavit of merit requirement, including when a minor is involved. Rather, we will require modification of the Judiciary’s electronic filing and notification case management system to ensure that, going forward, necessary and expected conferences are scheduled to enhance parties’ compliance with requirements under the Affidavit of Merit Statute (AMS or the statute), N.J.S.A. 2A:53A-26 to -29, in furtherance of the statutory policy goals." View "A.T. v. Cohen" on Justia Law